FindTrial
Sign In

Evaluation of treatment failure, relapse or recurrent Bacterial vaginosis infection

Evaluating the inflammatory, microbiome profile and co-infections in women diagnosed with treatment failure, relapse or recurrent Bacterial vaginosis -A Prospective analytic study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/01/048871
Enrollment
1067
Registered
2023-01-10
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R874- Abnormal immunological findings inspecimens from female genital organs

Interventions

None listed

Sponsors

ICMR Extramural grant
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 18-55 2. Sexually active 3. Women willing to come for follow up 4. Women having single sexual partners

Exclusion criteria

Exclusion criteria: 1. Asymptomatic women first time 2. Women not taken any antibiotic or antifungal for last 4 weeks 3. Have hypersensitivity or a contraindication to all first line drugs used to treat BV

Design outcomes

Primary

MeasureTime frame
1.Identify the species common in treatment failure ,relapse and recurrent Bacterial vaginosis 2.It will help to know the prevalence of recurrent,relapse and treatment faliure BV Timepoint: 7 days,30-40,6 months,9 months,one year—

Secondary

MeasureTime frame
1.Common Sexually transmitted infections among women taking treatment for STITimepoint: one year—

Countries

India

Contacts

Public ContactDr Deepti Tandon

ICMR NIRRCH

gdeepti167@gmail.com02224192030

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026